Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphomaTatsuro Jo, Ritsuko Kubota‐Koketsu, Kazuto Shigematsu et al.|Anticancer Research|2020Cited by 13
Successful Treatment of a Patient with Brentuximab Vedotin-Refractory ALK-Negative Anaplastic Large Cell Lymphoma with RomidepsinTatsuro Jo, Kazuto Shigematsu, Takahiro Sakai et al.|Case Reports in Oncology|2020Cited by 4
Elevation of Memory Cytotoxic T Lymphocytes, Including Human T Lymphotropic Virus Type 1 Tax-Specific and Hepatitis Virus Type C-Specific Cytotoxic T Lymphocytes, in a Patient with Adult T-Cell Leukemia/Lymphoma and Hepatocellular CarcinomaTatsuro Jo, Jun Taguchi, Yohei Kaneko et al.|Case Reports in Oncology|2020Cited by 2
Induction of Effector and Memory Cellular Immunity in a Patient with Long-Term Complete Molecular Response to Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaTatsuro Jo, Jun Taguchi, Haruna Shioya et al.|Case Reports in Oncology|2020Cited by 2
Improved Overall Survival Among Newly Diagnosed Aggressive Adult T-Cell Leukemia/Lymphoma Patients Treated with Mogamulizumab Plus EPOCH Compared to Mogamulizumab Plus Vcap-AMP-VecpTatsuro Jo, Kazuto Shigematsu, Kaori Matsuzaka et al.|Blood|2019Cited by 1